Answers are grounded in this paper and cite their sources.
Introduction : Severe obesity-related glomerulopathy (ORG) progressing to end-stage renal disease (ESRD) represents a growing challenge in kidney transplantation. Metabolic bariatric surgery (MBS) is increasingly proposed as a “bridge” to transplantation, yet no preclinical model reproduces the clinical triad of advanced obesity, nephrotic renal failure, and surgical operability. We aimed to develop and characterize a dual-hit obese rat model of severe nephrotic renal dysfunction approaching end-stage renal disease (ESRD), compatible with bariatric surgery and orthotopic kidney transplantation (KT). Methods : Male Wistar rats were fed a high-fat diet for 16 weeks to induce obesity, followed by titrated transjugular adriamycin (ADR) injection (3–9 mg/kg) to induce nephropathy. Renal function (estimated creatinine clearance), nephrotic parameters (proteinuria, albumin, triglycerides), and histological injury were assessed. Surgical feasibility of sleeve gastrectomy (SG), Roux-en-Y gastric bypass (RYGB), and orthotopic KT was evaluated. Analyses were descriptive due to the exploratory design. Results : Transjugular ADR provided reproducible renal injury with reduced local complications compared to caudal injection. High doses (6–9 mg/kg) induced excessive early mortality. ADR 3–4 mg/kg established a severe nephrotic phenotype while preserving short-term survival, defining a surgical window. RYGB was associated with 100% early postoperative mortality (0/6) in these rats. In contrast, SG was feasible, with approximately half of operated animals surviving over 10 days (9/17). Histology demonstrated dose-dependent tubulointerstitial injury; after SG, inflammatory and acute tubular lesion scores were descriptively lower, although the small subgroup sizes preclude any efficacy interpretation. Orthotopic KT was technically achievable despite increased visceral adiposity, although long-term survival remained limited. Conclusion : We developed a reproducible dual-hit obese rat model of severe nephrotic renal dysfunction approaching ESRD that preserves surgical operability. These exploratory findings are hypothesis-generating and provide a platform to investigate metabolic bridge strategies and graft behavior in high-risk recipients with obesity and advanced renal disease.
No takes yet. Share an insight, caveat, or question.
Bertrand et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: